SmarterDx recognized as one of Modern Healthcare's 2025 Innovators Award Honorees
NEW YORK, April 15, 2025 /PRNewswire/ -- Today, Modern Healthcare announced SmarterDx, the leader in clinical AI for revenue integrity and care quality, as one of Modern Healthcare's 2025 Innovators. The program celebrates both outstanding individuals and organizations leading healthcare innovation.
SmarterDx provides hospitals and health systems with clinical AI that helps them analyze the complete record of every patient to fully capture the value of care provided. Founded by physician-data scientists, their proprietary AI platform, featuring solutions SmarterPrebill ™ and SmarterDenials ™, empowers hospitals to improve quality of care scores and capture an average of $2 million in annual net new revenue per 10,000 patient discharges, achieving a 5:1 ROI. SmarterDx's solutions are leveling the playing field for clinicians and health systems, allowing them to achieve their clinical, operational, and financial goals.
'Our hospital and health system customers partner with SmarterDx because we deliver results: more accurate records and codes, fewer denials, and stronger margins,' said Michael Gao, MD, CEO and co-founder of SmarterDx. 'This recognition from Modern Healthcare reinforces what we hear from our customers — that AI can make a real difference when it's designed to understand the full clinical story.'
'Artificial intelligence, the use of data, and technology investments are transforming healthcare — streamlining workflows, improving patient care and creating new business opportunities,' said Mary Ellen Podmolik, editor-in-chief of Modern Healthcare. 'The ambitious work underway by our 2025 Innovators Awards' honorees is producing exciting results that will lead to better results for patients and these organizations that are tackling the industry's biggest challenges.'
SmarterDx has experienced rapid growth since launching its revenue cycle management solutions in 2020. SmarterDx's solutions are trusted by over 40+ health systems and 150+ hospital sites across the U.S.
About SmarterDx
SmarterDx builds clinical AI that empowers hospitals to analyze the complete record of every patient to fully capture the value of care delivered. Founded by physicians in 2020, its proprietary AI platform understands the nuances of clinical reasoning, enabling hospitals to be true to the patient record for every discharge. By doing so, hospitals can recover millions in earned revenue, enhance care quality metrics, and optimize healthcare operations. Discover how SmarterDx is transforming healthcare at smarterdx.com.
About Modern Healthcare
Modern Healthcare is the most trusted business news and information brand in the healthcare industry. Modern Healthcare empowers healthcare leaders and influencers to make timely and informed business decisions. To learn more or subscribe, go to www.modernhealthcare.com/subscriptions.
CONTACT:
Bethany Dufresne
AOx3
[email protected]
View original content to download multimedia: https://www.prnewswire.com/news-releases/smarterdx-recognized-as-one-of-modern-healthcares-2025-innovators-award-honorees-302428230.html
SOURCE SmarterDx
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Akesis Biologics Launches MastGut: A Breakthrough Supplement That Uses DUSP10 Enzyme to Support Gut and Colorectal Health
SINGAPORE, June 10, 2025 /PRNewswire/ -- Akesis Biologics, a biotechnology spin-off from the National University of Singapore (NUS), has officially launched its flagship gut health product, MastGut — a pioneering supplement that delivers therapeutic protection directly to the gut. Built on years of academic research and published findings in Nature Oncogene, MastGut brings an innovative approach to the consumer health space: using probiotic delivery of the DUSP10[1] enzyme to reduce gut inflammation and support long-term colorectal health. Colorectal cancer is the second leading cause of cancer-related deaths globally, and gut inflammation is on the rise in modern lifestyles. MastGut is developed with a novel, science-inspired approach grounded in academic research, aiming to support overall gut wellness through carefully selected ingredients.. "Most people think of probiotics as general digestive aids," says Prof. Zhang Yongliang, Co-founder and CEO of Akesis. "MastGut takes it much further. We intend to deliver an active functional protein that regulates inflammation and suppresses tumor-promoting enzyme activities — all using a probiotic vehicle." What is DUSP10[1]? A Scientific Breakthrough in Gut Health Unlike traditional supplements that rely on herbs or general bacterial strains, MastGut uses Lactococcus lactis, a food-grade probiotic commonly found in fermented dairy, as a delivery vehicle, to transport an enzyme known to reduce inflammation and suppress overactive cellular signalling underlying the development of colorectal cancer. This innovative method allows DUSP10 to be directly absorbed by intestinal cells, where it gets to work — without colonizing the gut. A Scientific Approach to Everyday Wellness DUSP10's function is well documented in cancer biology. Studies show that it acts as a brake on the MAPK pathway, a chain of molecular signals often overactivated in gut inflammation and cancer. In knockout mouse models, loss of DUSP10 led to increased tumor formation and gut damage. In contrast, higher expression of DUSP10 in human patients has been linked to better colorectal cancer outcomes. MastGut harnesses this science in a consumer-friendly format: a daily capsule that delivers the benefits of DUSP10 safely and effectively. "This isn't just another supplement. MastGut sits at the intersection of therapeutic treatment and nutritional science," says Dr. Chin Wen Png, Co-founder and CTO of Akesis. "It's for people who care about long-term gut health, cancer risk management, and the science behind what they put in their body." A New Frontier in Gut & Cancer Prevention MastGut represents a breakthrough in the way we think about preventive healthcare. By harnessing protein science to address inflammation and tumor suppression, it has the potential to benefit millions living with digestive discomfort, chronic inflammation, or increased colorectal cancer risk. "We are proud to see the launch of MastGut by Akesis Biologics, an NUS spin-off nurtured through our Graduate Research Innovation Programme (GRIP). This achievement underscores how NUS Enterprise's support and mentorship can transform cutting-edge research into impactful, real-world solutions. Akesis Biologics' successful journey from lab to market exemplifies our ongoing commitment to nurturing deep tech ventures and empowering them to create meaningful societal impact," said Associate Professor Benjamin Tee, Vice President (Ecosystem Building), NUS Enterprise. Akesis Biologics is currently engaging with hospitals, pharmacies, and research partners to broaden MastGut's access and impact across Asia and beyond. About Akesis Biologics Founded by leading scientists from NUS, Akesis Biologics is a Singapore-based biotech company focused on development of products to improve gut health. With expertise in inflammation, cancer biology, and clinical translation, Akesis aims to bridge the gap between academic innovation and practical health solutions. MastGut is the company's first commercial product, backed by years of R&D, IP protection, and real-world applicability. Reference: [1]Png, C.W., Weerasooriya, M., Guo, J., James, S.J., Poh, H.M., Osato, M., Flavell, R.A., Dong, C., Yang, H., and Zhang, Y. 2016. DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis. Oncogene 35:206-17. PMID: 25772234 View original content: SOURCE Akesis Biologics Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Virginia Tech Study Finds Aging Life Care Managers® Deliver Critical Support, Trust, and Peace of Mind to Families Navigating Aging and Caregiving
TUCSON, Ariz., June 9, 2025 /PRNewswire/ -- A recent national study by researchers at Virginia Tech confirms the significant impact Aging Life Care Managers® have on families and older adults facing the challenges of aging and caregiving. The study highlights the essential role these professionals play in improving care quality, easing emotional burdens, and providing clarity during times of uncertainty. Aging Life Care Managers are trained experts in aging, disability, and care coordination. They offer comprehensive support to families managing complex health conditions, navigating transitions, and coordinating services, while also serving as compassionate advocates and trusted partners in care. Study Highlights Profound Impact on Families and Individuals The two-phase research project, led by Dr. E. C. Shealy, Dr. P. B. Teaster, Dr. L. Sands, and Dr. J. Gray, involved in-depth interviews and a nationwide survey of current and former clients of Aging Life Care Managers. Findings reveal an overwhelmingly positive experience among families: 99% would recommend an Aging Life Care Manager 97% felt gratitude for the support received 93% said the value of the service outweighed the cost Respondents frequently described their Aging Life Care Managers as "lifelines," especially in emergencies or when navigating complex family dynamics. Long-distance caregivers, in particular, expressed relief at having a knowledgeable, local expert they could trust. A Model of Ethical, Compassionate Care The study emphasized the ethical and person-centered foundation of the Aging Life Care™ model. Nearly all respondents affirmed their Aging Life Care Manager's professionalism, confidentiality, and advocacy: 97% said Aging Life Care Managers helped mediate family dynamics 96% noted strong knowledge of local providers 95% confirmed their privacy was protected 94% credited their Aging Life Care Manager with supporting balanced decision-making "Aging Life Care Managers are not just professionals, they are partners, deeply committed to honoring the values and dignity of each client," said Pamela Teaster, Ph.D., professor and director of the Virginia Tech Center for Gerontology. Emotional and Practical Support Through Every Stage In addition to managing logistics, Aging Life Care Managers were praised for their emotional support and compassionate presence: 95% said their Aging Life Care Manager understood emotional challenges 91% found them responsive in crises 87% received help with care transitions Families also reported a significant improvement in quality of life for both clients and themselves: 97% reported feeling peace of mind 92% affirmed their future needs were anticipated 87% said the client was able to "live well" despite their challenges 82% experienced reduced isolation Client Testimonials Underscore Value Comments from survey participants highlighted the personal and lasting impact of their Aging Life Care Managers: "She's an extension of me.""It's worth every cent.""Even after her passing, the Aging Life Care Manager arranged a celebration." A Call to Action for Families Nationwide The findings affirm what many families have long known: Aging Life Care Managers offer critical support during some of life's most difficult times. Their unique blend of clinical knowledge, ethical practice, and emotional insight makes them essential partners in navigating aging, illness, and end-of-life care. For those caring for aging loved ones or planning ahead, the Aging Life Care Association offers a nationwide directory of qualified professionals. Visit to learn more. About the Study The study, commissioned by the Aging Life Care Association® (ALCA), surveyed members of the Aging Life Care Association and their clients. An Examination of the Aging Life Care Association: Part Two – Qualitative Client Interviews and Client Survey was presented at the Aging Life Care Association's 41st Annual Conference in Boston, MA. Findings will be presented at the Gerontological Society of America Scientific Meeting in November 2025. A summary of the study's findings can be found on the Aging Life Care Association's blog. About the Aging Life Care Association® (ALCA) The Aging Life Care Association® (ALCA) was formed in 1985 to advance dignified, coordinated care for older adults in the United States. With nearly 2,000 members nationwide, Aging Life Care Professionals® have cared for about two million older adults over its history. ALCA Members are distinguished from others practicing care management as they must meet stringent education, experience, and certification requirements and adhere to Code of Ethics and Standards of Practice. Members may be trained in several fields including, but not limited to, counseling, gerontology, mental health, nursing, occupational therapy, physical therapy, psychology, or social work; with a specialized focus on issues related to aging and elder care. For more information or to access a directory of Aging Life Care Professionals, please visit View original content to download multimedia: SOURCE Aging Life Care Association
Yahoo
an hour ago
- Yahoo
ProstaChew Announces Official Website Update Featuring Natural Daily Supplement for Prostate and Urinary Health
Chewable Men's Health Formula Designed to Promote Normal Prostate Size, Bladder Comfort, and Urinary Flow Now Highlighted on Updated Website SHERIDAN, June 09, 2025 (GLOBE NEWSWIRE) -- ProstaChew™, a wellness supplement brand from Aspen Brass LLC, has updated its official website to highlight a natural chewable formula developed to support prostate function and urinary health in adult men. Available nationwide, the supplement is designed for those seeking an easy-to-use daily routine that fits seamlessly into modern lifestyles. According to the official product website ( ProstaChew™ aims to support the body's natural ability to maintain a healthy prostate size, promote normal urinary flow, and ease age-related urinary discomfort. The supplement's chewable delivery format was created to simplify daily use—no capsules or water required. 'We wanted to make prostate support more approachable for the average man,' said a ProstaChew™ spokesperson. 'This formula represents our belief that men deserve high-quality, natural solutions that support confidence and long-term wellness.' The company affirms that ProstaChew™ is manufactured in U.S. facilities that follow strict quality and safety protocols. Its ingredients are chosen to align with common men's health goals, including bladder comfort, urinary regularity, and healthy inflammation support. As detailed on the updated website, ProstaChew™ includes a satisfaction guarantee for new customers. Those interested in learning more or purchasing directly can find product details, ingredient information, FAQs, and ordering options online. About ProstaChew™ ProstaChew™, a supplement brand by Aspen Brass LLC, is focused on delivering natural, effective health solutions for men. With an emphasis on convenience, transparency, and quality, the brand offers daily-use formulas designed to support common age-related wellness concerns, including prostate and urinary function. Product and Contact Information Brand: ProstaChew™Company: Aspen Brass LLCWebsite: care@ +1 (866) 941-1082Business Address: 1309 Coffeen Ave Ste 17470, Sheridan, WY 82801Return Address: 4711 34th St N Suite F, St. Petersburg, FL 33714 Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The statements made about this product have not been evaluated by the Food and Drug Administration. Individual results may vary. Consumers should consult a qualified healthcare provider before beginning any new dietary supplement. CONTACT: Email: care@ Phone: +1 (866) 941-1082 Return Address: 4711 34th St N Suite F, St. Petersburg, FL 33714Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
